2018 Section 5 - Rhinology and Allergic Disorders

Steroid-eluting implant for recurrent NP

office-based alternative to revision surgery for the treat- ment of obstructive polyposis. Acknowledgments We thank the research staff at the study centers for their time and contribution to this research study. We would es- pecially like to acknowledge clinical research coordinators Holly Featherstone, CCRP (Intermountain ENT Special-

ists, Salt Lake City, UT), Kathleen Sheely (Advanced ENT and Allergy, Louisville, KY), JoAnn LoForti, RN (Central California ENT Medical Group, Fresno, CA), and Sharon Woodworth, RN, and Deborah Bothwell, CCRC (Col- orado ENT & Allergy, Colorado Springs, CO). Finally, we thank Vicki Schreckengost, MSN, Sally Glauz, and Jen- nifer Slocum, for the professional support they provided to the clinical sites.

References 1. Banerji A, Piccirillo JF, Thawley SE, et al. Chronic rhinosinusitis patients with polyps or polypoid mu- cosa have a greater burden of illness. Am J Rhinol . 2007;21:19–26. 2. Fokkens W, Lund V, Mullol J; European Position Pa- per on Rhinosinusitis and Nasal Polyps group. Eu- ropean Position Paper on Rhinosinusitis and Nasal Polyps 2007. Rhinol Suppl . 2007;(20):1–136. 3. Wynn R, Har-El G. Recurrence rates after endoscopic sinus surgery for massive sinus polyposis. Laryngo- scope . 2004;114:811–813. 4. Murr AH, Smith TL, Hwang PH, et al. Safety and efficacy of a novel bioabsorbable, steroid-eluting sinus stent. Int Forum Allergy Rhinol . 2011;1: 23–32. 5. Forwith KD, Chandra RK, Yun PT, et al. ADVANCE: a multi-site trial of bioabsorbable steroid-eluting sinus implants. Laryngoscope . 2011;121:2473– 2480. 6. Marple BF, Smith TL, Han JK, et al. AD- VANCE II: a prospective, randomized study assess- ing safety and efficacy of bioabsorbable steroid- releasing sinus implants. Otolaryngol Head Neck Surg . 2011;146:1004–1011. 7. Han JK, Marple BF, Smith TL, et al. Effect of steroid- releasing implants on postoperative medical and surgi- cal interventions: an efficacy meta-analysis. Int Forum Allergy Rhinol . 2012;2:271–279. 8. Meltzer EO, Hamilos DL, Hadley JA, et.al. Rhi- nosinusitis initiative. Rhinosinusitis: developing guid- ance for clinical trials. J Allergy Clin Immunol . 2006;118(Suppl 5):S17–S61. 9. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and ac-

18. Hoffman DF, May M, Mester SJ. Functional endo- scopic sinus surgery—experience with the initial 100 patients. Am J Rhinol . 1990;4:129–132. 19. Jakobsen J, Svendstrup F. Functional endoscopic si- nus surgery in chronic sinusitis—a series of 237 con- secutively operated patients. Acta Otolaryngol Suppl . 2000;543:158–161. 20. Tran KN, Beule AG, Singal D, Wormald PJ. Frontal ostium restenosis after the endoscopic modified Lothrop procedure. Laryngoscope . 2007;117:1457– 1462. 21. Soler ZM, Smith TL. Quality-of-life outcomes after endoscopic sinus surgery: How long is long enough? Otolaryngol Head Neck Surg . 2010;143:621–625. 22. Stjarne P, Mosges R, Jorissen M, et.al. A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis. Arch Otolaryngol Head Neck Surg . 2006;132:179–185. 23. Small CB, Hernandez J, Reyes A, et.al. Efficacy and safety of mometasone furoate nasal spray in nasal polyposis. J Allergy Clin Immunol . 2005;116:1275– 1281. 24. Browne J, Hopkins C, Slack R, et al. The National Comparative Audit of Surgery for Nasal Polyposis and Chronic Rhinosinusitis . August 2003. London: Clinical Effectiveness Unit, Royal College of Surgeons of England. http://www.rcseng.ac.uk/publications/docs/national- comparative-audit-of-surgery-for-nasal-polyposis- and-chronic-rhinosinusitis-final-report. Accessed February 5, 2014. 25. Kuhn FA, Church CA, Goldberg AN, et al. Balloon catheter sinusotomy: one-year follow-up—outcomes and role in functional endoscopic sinus surgery. Oto- laryngol Head Neck Surg . 2008;139:S27-S37.

tivity impairment instrument. Pharmacoeconomics . 1993;4:353–365. 10. Piccirillo JF, Merritt MG, Richards ML. Psychomet- ric and clinimetric validity of the 20-Item Sino-Nasal Outcome Test (SNOT-20). Otolaryngol Head Neck Surg . 2002;126:41–47. 11. Hardy JG, Lee SW, Wilson CG. Intranasal drug delivery by spray and drops. J Pharm Pharmacol . 1985;37:294–297. 12. Aukema A, Mulder P, Fokkens WJ. Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery. J Allergy Clin Immunol . 2005;115:1017–1023. 13. van Camp C, Clement PA. Results of oral steroid treat- ment in nasal polyposis. Arch Otolaryngol Head Neck Surg . 1998;124:513–518. 14. Hissaria P, Smith W, Wormald PJ, et. al. Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measures. J Allergy Clin Immunol . 2006;118:128–133. 15. Murr AH, Goldberg AN, Vesper S. Fungal speciation using quantitative polymerase chain reaction (QPCR) in patients with and without chronic rhinosinusitis. Laryngoscope . 2006;116:1342–1348. 16. Ferguson BJ, Otto BA, Pant H, When surgery, antibi- otics, and steroids fail to resolve chronic rhinosinusi- tis. Immunol Allergy Clin North Am . 2009;29:719– 732. 17. Vaidyanathan S, Barnes M, Williamson P, Hop- kinson P, Donnan PT, Lipworth B. Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by topical steroids. Ann Intern Med . 2011;154:293–302.

International Forum of Allergy & Rhinology, Vol. 4, No. 4, May 2014

240